Fig. 1
From: Pulegone induced apoptotic and anti-proliferative potential in cervical cancer via P53, BAX and BCL2
Effects of Pulegone on (A) HeLa (cervical cancer), (B) VERO (normal cells) cells (C) CaSki cells and (D) SiHa cells. HeLa, VERO, CaSki and SiHa cells treated with increasing concentration of Pulegone for 12, 24 and 48 h, respectively. Data are the mean ± SD of at least three independent experiments. Pulegone 10 µM dose showed significantly more cytotoxicity compared with all other groups including Cisplatin (positive control). Where ***, **, * showing P ≤ 0.001, P ≤ 0.01, P ≤ 0.05 respectively.
